• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Trending

Earning Release

2025.11.20 (EST) Announced FY2025 Cumulative 3Q Earning Release (USD) Revenue 0, Net Income -7.122 M, EPS -1.2578

Event Tracking

Nov21
Chemomab Therapeutics released FY2025 Q3 earnings on November 20 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.32 (forecast USD -0.22)
04:00
Chemomab Therapeutics released FY2025 9 Months Earnings on November 20, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.2578
04:00
Aug15
Chemomab Therapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.355 (forecast USD -0.04)
03:00
Chemomab Therapeutics released FY2025 Semi-Annual Earnings on August 14 (EST), with actual revenue of USD 0 and EPS of USD -0.9359
03:00
Jul1
Chemomab Therapeutics Ltd. Holds Annual General Meeting
20:06
Jun30
Chemomab Therapeutics' nebokitug Phase II Trial Results Positive
12:00

Schedules & Filings

Schedules
Filings
Nov20
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -1.742 M, EPS -0.32

Aug26
Reverse Stock Split(EST)

1-for-4 Reverse Stock Split

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.057 M, EPS -0.355

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FOXX
3.650
+80.60%
+1.616
MNDR
4.755
+56.41%
+1.715
NVVE
0.2495
+52.04%
+0.081
DVLT
2.540
+45.97%
+0.770
PTN
21.115
+45.72%
+6.110
IVDA
0.9383
+44.24%
+0.266
SEVNR
0.0400
+43.88%
+0.008
CCTG
0.2226
+34.66%
+0.066
BEAGR
0.3990
+32.56%
+0.098
OSRH
0.5976
+31.05%
+0.152
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy